Oncotelic Therapeutics, Inc. Business Development
Oncotelic Therapeutics, Inc. (OTLC) reported Business Development of $1.20 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2025-11-17
- 2025-09-30: Business Development 9 month $1.20M.
| Period end | Business Development 9 month |
|---|---|
| 2025-09-30 | $1.20M 10-Q · filed 2025-11-17 |